Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Prognostic relevance of glycosylation-associated genes in breast cancer.

Milde-Langosch K, Karn T, Schmidt M, zu Eulenburg C, Oliveira-Ferrer L, Wirtz RM, Schumacher U, Witzel I, Schütze D, Müller V.

Breast Cancer Res Treat. 2014 Jun;145(2):295-305. doi: 10.1007/s10549-014-2949-z. Epub 2014 Apr 16.

PMID:
24737166
[PubMed - in process]
2.

Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.

Klopfleisch R, Lenze D, Hummel M, Gruber AD.

BMC Cancer. 2010 Nov 9;10:618. doi: 10.1186/1471-2407-10-618.

PMID:
21062462
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

Milde-Langosch K, Karn T, Müller V, Witzel I, Rody A, Schmidt M, Wirtz RM.

Breast Cancer Res Treat. 2013 Jan;137(1):57-67. doi: 10.1007/s10549-012-2296-x. Epub 2012 Nov 8.

PMID:
23135572
[PubMed - indexed for MEDLINE]
4.

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.

Potapenko IO, Haakensen VD, Lüders T, Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC, Børresen-Dale AL.

Mol Oncol. 2010 Apr;4(2):98-118. doi: 10.1016/j.molonc.2009.12.001. Epub 2009 Dec 11. Review.

PMID:
20060370
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
[PubMed - indexed for MEDLINE]
7.

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

Karn T, Pusztai L, Holtrich U, Iwamoto T, Shiang CY, Schmidt M, Müller V, Solbach C, Gaetje R, Hanker L, Ahr A, Liedtke C, Ruckhäberle E, Kaufmann M, Rody A.

PLoS One. 2011;6(12):e28403. doi: 10.1371/journal.pone.0028403. Epub 2011 Dec 29.

PMID:
22220191
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.

Al-Mulla F, Marafie M, Zea Tan T, Paul Thiery J.

J Cell Biochem. 2014 Mar;115(3):488-97. doi: 10.1002/jcb.24682.

PMID:
24123286
[PubMed - indexed for MEDLINE]
9.

MMP-1 expression has an independent prognostic value in breast cancer.

Boström P, Söderström M, Vahlberg T, Söderström KO, Roberts PJ, Carpén O, Hirsimäki P.

BMC Cancer. 2011 Aug 11;11:348. doi: 10.1186/1471-2407-11-348.

PMID:
21835023
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.

Kuo WH, Chang YY, Lai LC, Tsai MH, Hsiao CK, Chang KJ, Chuang EY.

PLoS One. 2012;7(9):e45831. doi: 10.1371/journal.pone.0045831. Epub 2012 Sep 25.

PMID:
23049873
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.

Specht K, Harbeck N, Smida J, Annecke K, Reich U, Naehrig J, Langer R, Mages J, Busch R, Kruse E, Klein-Hitpass L, Schmitt M, Kiechle M, Hoefler H.

Breast Cancer Res Treat. 2009 Nov;118(1):45-56. doi: 10.1007/s10549-008-0207-y. Epub 2008 Oct 17.

PMID:
18925433
[PubMed - indexed for MEDLINE]
12.

Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer.

He H, Shen Z, Zhang H, Wang X, Tang Z, Xu J, Sun Y.

Br J Cancer. 2014 Apr 15;110(8):2021-9. doi: 10.1038/bjc.2014.93. Epub 2014 Mar 11.

PMID:
24619076
[PubMed - indexed for MEDLINE]
13.

Expression profiling of ion channel genes predicts clinical outcome in breast cancer.

Ko JH, Ko EA, Gu W, Lim I, Bang H, Zhou T.

Mol Cancer. 2013 Sep 22;12(1):106. doi: 10.1186/1476-4598-12-106.

PMID:
24053408
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The humoral immune system has a key prognostic impact in node-negative breast cancer.

Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H, Gehrmann M.

Cancer Res. 2008 Jul 1;68(13):5405-13. doi: 10.1158/0008-5472.CAN-07-5206.

PMID:
18593943
[PubMed - indexed for MEDLINE]
Free Article
15.

Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.

Schmidt M, Petry IB, Böhm D, Lebrecht A, von Törne C, Gebhard S, Gerhold-Ay A, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenführer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG.

Breast Cancer Res Treat. 2011 Feb;125(3):637-46. doi: 10.1007/s10549-010-0856-5. Epub 2010 Mar 30.

PMID:
20352488
[PubMed - indexed for MEDLINE]
16.

Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.

Wiens AL, Martin SE, Bertsch EC, Vance GH, Stohler RA, Cheng L, Badve S, Hattab EM.

Arch Pathol Lab Med. 2014 Feb;138(2):175-81. doi: 10.5858/arpa.2012-0541-OA.

PMID:
24476516
[PubMed - indexed for MEDLINE]
17.

CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.

Dietrich D, Krispin M, Dietrich J, Fassbender A, Lewin J, Harbeck N, Schmitt M, Eppenberger-Castori S, Vuaroqueaux V, Spyratos F, Foekens JA, Lesche R, Martens JW.

BMC Cancer. 2010 Jun 1;10:247. doi: 10.1186/1471-2407-10-247.

PMID:
20515469
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?

Albergaria A, Ricardo S, Milanezi F, Carneiro V, Amendoeira I, Vieira D, Cameselle-Teijeiro J, Schmitt F.

BMC Cancer. 2011 Jul 15;11:299. doi: 10.1186/1471-2407-11-299.

PMID:
21762477
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.

Lee LY, Thaysen-Andersen M, Baker MS, Packer NH, Hancock WS, Fanayan S.

J Proteome Res. 2014 Nov 7;13(11):4783-95. doi: 10.1021/pr500331m. Epub 2014 Sep 11.

PMID:
25210975
[PubMed - in process]
20.

A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.

Sutcliffe P, Connock M, Shyangdan D, Court R, Kandala NB, Clarke A.

Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420. Review.

PMID:
24070110
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk